Skip to content

A Novel Lung Function Imaging Modality As a Preoperative Evaluation Tool (LIME)

A Novel Lung Function Imaging Modality As a Preoperative Evaluation Tool (LIME)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03426306
Enrollment
65
Registered
2018-02-08
Start date
2018-03-21
Completion date
2022-01-18
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

4-Dimensional Computed Tomography

Brief summary

To evaluate the correlation between pre-surgical 4DCT-ventilation imaging and post-surgical lung function.

Detailed description

To evaluate the correlation between pre-surgical 4-Dimensional Computed Tomography-ventilation (4DCT-ventilation) imaging and post-surgical lung function. To determine whether 4DCT-ventilation is a better predictor of post-surgical lung function than nuclear medicine imaging using pulmonary function tests (PFTs). To determine whether 4DCT-ventilation is a better predictor of post-surgical lung function than nuclear medicine imaging using quality of life (QOL) questionnaires. Evaluate cost-effectiveness of using 4DCT-ventialtion and VQ scans for pre-surgical assessment. To use longitudinal (pre and post-surgical) 4DCT-ventilation imaging to derive novel post-surgical prediction formulas.

Interventions

DIAGNOSTIC_TEST4DCT-Ventilation

4DCT-ventilation is an imaging modality that provides superior image quality, reduced cost, and a faster imaging procedure compared to nuclear medicine VQ scans.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. Provision to sign and date the consent form. 2. Stated willingness to comply with all required (non-optional) study procedures and be available for the duration of the study. 3. Be a male or female aged 18 to 100. 4. Patient with lung cancer (presumed or biopsy proven) currently undergoing or having undergone evaluation for resection. 5. Lung function assessment required for pre-surgical evaluation at the discretion of the cardiothoracic surgeon. 6. Life expectancy greater than 3 months.

Exclusion criteria

1\. Patients getting a planned wedge resection as the only thoracic resectional procedure.

Design outcomes

Primary

MeasureTime frameDescription
Pre-Surgical Imaging and Post-Surgical Lung FunctionBaseline visit to follow up visit, up to 9 months.Measure the correlation between pre-surgical 4-Dimensional Computed Tomography-ventilation (4DCT) imaging and post surgical lung function using a Percent Predicted Post-Operative Pulmonary Function Test (%PPO PFT).

Secondary

MeasureTime frameDescription
Ability of %PPO PFTsStart of study to end of study, up to 2 yearsUse %PPO PFTs to determine if 4DCT-ventilation is a better predictor of post surgical lung function than nuclear medicine imaging
Quality of Life (QOL)Start of study to end of study, up to 2 yearsUse QOL questionnaires to determine if 4DCT-ventilation is a better predictor of post surgical lung function than nuclear medicine imaging.
Cost-EffectivenessStart of study to end of study, up to 2 yearsDetermine the cost-effectiveness of 4DCT-ventialtion and VQ scans for pre-surgical assessment using Receiver Operator Characteristic (ROC) analysis.
Longitudinal Imaging ChangesStart of study to end of study, up to 2 yearsDerive novel post-surgical prediction formulas using longitudinal 4DCT-ventilation imaging

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026